Nektar Therapeutics | NKTR - 净收入



金融业
股票价格
USD
资产
USD 763.27M
现金及等价物
USD 149.58M
销售成本
USD 4.44M
流动资产
USD 589.04M
流动负债
USD 57.71M
债务
USD 0
股息收益率
0
EBIT
USD -38.26M
EBITDA
USD -38.9M
员工
137
EPS每股收益
USD -1.78
股本和储备
USD 576.22M
销售毛利
USD 10.86M
债务利息支出
USD 7.94M
利息收入
USD -0.18
贷款资金
USD 60.27M
市值
USD 14.14B
净收入
USD -44.9M
营业费用
USD 49.12M
营业利润
USD -38.26M
普通股股本
USD 29.47M
税前利润
USD -43.09M
销售收入
USD 10.86M
销售和管理费用
USD 11.87M
股票
USD 14.46M
贸易债权人
USD 10.03M
应收帐款人
USD 3.6M


净收入 更改 日
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
ALKERMES USD 501K 66.98M 2026-06
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Amgen USD 2.38B 556M 2026-06
Baxter International USD 126M 141M 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Biogen USD 97.5M 222M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Cara Therapeutics USD -6.8M 1.28M 2026-03
Cipla INR 7.89B 2.34B 2026-06
Dr.Reddys Laboratories INR 4.44B 2.23B 2026-06
Eisai JPY 18.24B 21.49B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Exelixis USD 212.05M 1.58M 2026-06
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Grifols EUR 114.37M 34.03M 2025-12
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Incyte USD 585.6M 282.27M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
MacroGenics USD -36.77M 22.62M 2026-03
Merck USD -1.34B 2.9B 2026-06
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novartis USD 3.26B 108M 2026-06
Pfizer USD -248M 2.94B 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
Takeda JPY 113.2B 137.52B 2026-06
Teva Pharmaceutical Industries USD -576M 945M 2026-06
Xencor USD -21.73M 107.19M 2026-06